REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/03/2026
Voltar para busca
Dado oficial do USPTO
BIOLOGIC BUILDING BLOCKS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOLOGIC BUILDING BLOCKS
ST13
US500000087307441Classe
1, 42
Pedido
87307441
Registro
6289605
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
10/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 42
Data de depósito
19/01/2017
Data de registro
09/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/03/2021
Última transação
10/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
20/07/2020
Primeiro uso no comércio
20/07/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
Waukegan, IL, US
Examinador
JOHNSON, AISHA CLARKE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Pfanstiehl, Inc.
Representantes
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
Classificação técnica
Classes Nice
Classe 1Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
Classe 42
Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/02/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/01/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/01/2021
IUAF
USE AMENDMENT FILED
10/09/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/03/2020
EX5G
SOU EXTENSION 5 GRANTED
18/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
18/03/2020
EXT5
SOU EXTENSION 5 FILED
10/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/09/2019
EX4G
SOU EXTENSION 4 GRANTED
11/09/2019
EXT4
SOU EXTENSION 4 FILED
11/09/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/09/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/03/2019
EX3G
SOU EXTENSION 3 GRANTED
06/03/2019
EXT3
SOU EXTENSION 3 FILED
06/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2018
EX2G
SOU EXTENSION 2 GRANTED
10/09/2018
EXT2
SOU EXTENSION 2 FILED
10/09/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/09/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/03/2018
EX1G
SOU EXTENSION 1 GRANTED
09/03/2018
EXT1
SOU EXTENSION 1 FILED
09/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/07/2017
PUBO
PUBLISHED FOR OPPOSITION
18/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/04/2017
GNRT
NON-FINAL ACTION E-MAILED
25/04/2017
CNRT
NON-FINAL ACTION WRITTEN
25/04/2017
DOCK
ASSIGNED TO EXAMINER
14/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/01/2017
NWAP
NEW APPLICATION ENTERED
23/01/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOLOGIC BUILDING BLOCKS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.